An improved understanding of TNFL/TNFR interactions using structure-based classifications

Trends in Biochemical Sciences

Volumn 37, Issue 9, 2012, Pages 353-363

  Magis, Cedrik ^a   van der Sloot, Almer M ^a   Serrano, Luis ^a,b   Notredame, Cedric ^a  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Evolution; MSA; Structure based classification; TNFL; TNFR

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CD40 LIGAND; CYSTEINE; LYMPHOTOXIN; OSTEOCLAST DIFFERENTIATION FACTOR; OX40 LIGAND; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 10B; TUMOR NECROSIS FACTOR RECEPTOR 11A; TUMOR NECROSIS FACTOR RECEPTOR 12; TUMOR NECROSIS FACTOR RECEPTOR 13B; TUMOR NECROSIS FACTOR RECEPTOR 13C; TUMOR NECROSIS FACTOR RECEPTOR 14; TUMOR NECROSIS FACTOR RECEPTOR 16; TUMOR NECROSIS FACTOR RECEPTOR 17; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR 21; TUMOR NECROSIS FACTOR RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR 5; TUMOR NECROSIS FACTOR RECEPTOR 6B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

AMINO TERMINAL SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; TREE BASED ON ROOT MEAN SQUARE DEVIATION;

ANIMALS; HUMANS; LIGANDS; PHYLOGENY; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 84865435966     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.06.002     Document Type: Review

References (64)

1. Gaur U., Aggarwal B.B. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol. 2003, 66:1403-1408.
2. Locksley R.M., et al. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
3. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
4. Hehlgans T., Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005, 115:1-20.
5. Clark I.A. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 2007, 18:335-343.
6. Tansey M.G., Szymkowski D.E. The TNF superfamily in 2009: new pathways, new indications, and new drugs. Drug Discov. Today 2009, 14:1082-1088.
7. Grewal I.S. Overview of TNF superfamily: a chest full of potential therapeutic targets. Adv. Exp. Med. Biol. 2009, 647:1-7.
8. Bossen C., et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 2006, 281:13964-13971.
9. Zhang G. Tumor necrosis factor family ligand-receptor binding. Curr. Opin. Struct. Biol. 2004, 14:154-160.
10. Pradet-Balade B., et al. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J. 2002, 21:5711-5720.
11. Hymowitz S.G., et al. The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificity. Structure 2003, 11:1513-1520.
12. Bodmer J.L., et al. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 2002, 27:19-26.
13. Kishore U., et al. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol. 2004, 25:551-561.
14. Ghebrehiwet B., et al. The C1q family of proteins: insights into the emerging non-traditional functions. Front. Immunol. 2012, 3:52.
15. Bazan J.F. Emerging families of cytokines and receptors. Curr. Biol. 1993, 3:603-606.
16. Naismith J.H., Sprang S.R. Modularity in the TNF-receptor family. Trends Biochem. Sci. 1998, 23:74-79.
17. Chan F.K., et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 2000, 288:2351-2354.
18. Clancy L., et al. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18099-18104.
19. Chan F.K. Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 2007, 37:101-107.
20. Sedger L.M., et al. Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death. J. Virol. 2006, 80:9300-9309.
21. Kramer J.M., et al. Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor. J. Immunol. 2007, 179:6379-6383.
22. Chan F.K. The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function. Ann. Rheum. Dis. 2000, 59(Suppl. 1):i50-i53.
23. Branschadel M., et al. Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: conformational stabilization of CRD2 and control of receptor responsiveness. Cell. Signal. 2010, 22:404-414.
24. Mongkolsapaya J., et al. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat. Struct. Biol. 1999, 6:1048-1053.
25. Banner D.W., et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993, 73:431-445.
26. Mukai Y., et al. Solution of the structure of the TNF-TNFR2 complex. Sci. Signal. 2010, 3:ra83.
27. Zhan C., et al. Decoy strategies: the structure of TL1A:DcR3 complex. Structure 2011, 19:162-171.
28. Liu C., et al. Structural and functional insights of RANKL-RANK interaction and signaling. J. Immunol. 2010, 184:6910-6919.
29. Compaan D.M., Hymowitz S.G. The crystal structure of the costimulatory OX40-OX40L complex. Structure 2006, 14:1321-1330.
30. Hymowitz S.G., et al. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J. Biol. Chem. 2005, 280:7218-7227.
31. Hymowitz S.G., et al. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell 1999, 4:563-571.
32. Cha S.S., et al. Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity. J. Biol. Chem. 2000, 275:31171-31177.
33. Notredame C., et al. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 2000, 302:205-217.
34. Taly J.F., et al. Using the T-Coffee package to build multiple sequence alignments of protein, RNA, DNA sequences and 3D structures. Nat. Protoc. 2011, 6:1669-1682.
35. Holm L., et al. Using Dali for structural comparison of proteins. Curr. Protoc. Bioinform. 2006, Chapter 5, Unit 5.5. 10.1002/0471250953.bi0505s14.
36. Punta M., et al. The Pfam protein families database. Nucleic Acids Res. 2012, 40:D290-D301.
37. Letunic I., et al. SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res. 2012, 40:D302-D305.
38. Sigrist C.J., et al. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res. 2010, 38:D161-D166.
39. Chattopadhyay K., et al. Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: implications for function. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19452-19457.
40. Armougom F., et al. Expresso: automatic incorporation of structural information in multiple sequence alignments using 3D-Coffee. Nucleic Acids Res. 2006, 34:W604-W608.
41. Magis C., et al. T-RMSD: a fine-grained, structure-based classification method and its application to the functional characterization of TNF receptors. J. Mol. Biol. 2010, 400:605-617.
42. Glenney G.W., Wiens G.D. Early diversification of the TNF superfamily in teleosts: genomic characterization and expression analysis. J. Immunol. 2007, 178:7955-7973.
43. Eddy S.R. Profile hidden Markov models. Bioinformatics 1998, 14:755-763.
44. Won E.Y., et al. The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily. J. Biol. Chem. 2010, 285:9202-9210.
45. Kuester M., et al. The crystal structure of death receptor 6 (DR6): a potential receptor of the amyloid precursor protein (APP). J. Mol. Biol. 2011, 409:189-201.
46. An H.J., et al. Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation. J. Biol. Chem. 2011, 286:11226-11235.
47. Mackay F., Schneider P. Cracking the BAFF code. Nat. Rev. Immunol. 2009, 9:491-502.
48. Bossen C., Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 2006, 18:263-275.
49. Tur V., et al. DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design. J. Biol. Chem. 2008, 283:20560-20568.
50. Wiens G.D., Glenney G.W. Origin and evolution of TNF and TNF receptor superfamilies. Dev. Comp. Immunol. 2011, 35:1324-1335.
51. Collette Y., et al. A co-evolution perspective of the TNFSF and TNFRSF families in the immune system. Trends Immunol. 2003, 24:387-394.
52. Jordan G.E., Piel W.H. PhyloWidget: web-based visualizations for the tree of life. Bioinformatics 2008, 24:1641-1642.
53. Eck M.J., Sprang S.R. The structure of tumor necrosis factor-alpha at 2.6 A resolution Implications for receptor binding. J. Biol. Chem. 1989, 264:17595-17605.
54. Karpusas M., et al. 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995, 3:1031-1039.
55. Liu Y., et al. Ligand-receptor binding revealed by the TNF family member TALL-1. Nature 2003, 423:49-56.
56. Jin T., et al. X-ray crystal structure of TNF ligand family member TL1A at 2.1A. Biochem. Biophys. Res. Commun. 2007, 364:1-6.
57. Gaboriaud C., et al. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J. Biol. Chem. 2003, 278:46974-46982.
58. Kvansakul M., et al. Crystal structure of the collagen alpha1(VIII) NC1 trimer. Matrix Biol. 2003, 22:145-152.
59. Bogin O., et al. Insight into Schmid metaphyseal chondrodysplasia from the crystal structure of the collagen X NC1 domain trimer. Structure 2002, 10:165-173.
60. Naismith J.H., et al. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 1996, 4:1251-1262.
61. He F., et al. Solution structure of the cysteine-rich domain in Fn14, a member of the tumor necrosis factor receptor superfamily. Protein Sci. 2009, 18:650-656.
62. Carfi A., et al. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell 2001, 8:169-179.
63. He X.L., Garcia K.C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004, 304:870-875.
64. Graham S.C., et al. Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J. Mol. Biol. 2007, 372:660-671.